蝮蛇抗栓酶(清栓酶)对实验性玻璃体积血的疗效探讨  

THERAPEUTIC EVALUATION OF QINGSHUANMEI TO TREAT EXPERIMENTAL VITREOUS HEMORRHAGE

作　　者：周国筠[1] 骆荣江[1] 

机构地区：[1]中国人民解放军第一军医大学南方医院眼科

出　　处：《蛇志》1992年第3期9-11,共3页Journal of Snake

摘　　要：玻璃体积血是眼外伤及某些眼病的常见并发症,且常严重损害视功能,为了寻找一种在早期能促进玻璃体积血吸收而又使用方便的药物,我们用^(51)铬标记红细胞之全血制成玻璃体积血模型,对蝮蛇抗栓酶(清栓酶)的疗效进行观察,结果证明蝮蛇抗栓酶对实验性玻璃体积血的清除有显著效果(P<0.001).Vitreou nemorrhage is usual complication of eye injury and some ophthalmoputhies and ofter seriously damages visual funetion.In order to seek a drug of promoting absorption of vitreous hemorrhage,we used whole blood(^(51)Cr register RBC)to make the model of vitreous hemorrhage and observed the effect of Qingshuanmei to treat vitreous hemorrhage.The results shown that Qingshuanmci had significant curative effect for clearing of experimental vitreous hemorrhage.

关 键 词：玻璃体积血 蝮蛇抗栓酶 

分 类 号：R988.1[医药卫生—药品]